Hydrocortisone for treating hypotension in preterm infants:A meta-analysis
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective:To discuss the efficacy of hydrocortisone for treating hypotension and reduction of vasopressor requirements in preterm infants. Methods:A search in Cochrane Library,PubMed,Ovid,Springer was performed to identify relevant articles according to the inclusion criteria. Standard meta-analytic techniques,including random and fixed effects models,were used to calculate combined effect size correlations and significance levels. Results:Seven studies were included,with total 144 newborns,144 cases in Hydrocortisone group and 93 cases in Hydrocortisone and inotrope group. Random effects meta-analysis showed that hydrocortisone increases blood pressure (r = 0.74,95%CI:0.16 to 0.91) and reduces vasopressor requirement (r = 0.72,95%CI:0.0124 to 0.96). Conclusion:Hydrocortisone is effective in treatment of refractory hypotension and decreasing vasopressor requirements in preterm without an increase in short term adverse consequences. However,the long term safety data on the use of hydrocortisone is unknown.

    Reference
    Related
    Cited by
Get Citation

何 帆,高才杰,吴伟玲,魏永越,郑大同.氢化可的松治疗早产儿低血压疗效的Meta分析[J].南京医科大学学报(自然科学版英文版),2014,(2):265-271.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:June 13,2013
  • Revised:
  • Adopted:
  • Online: March 03,2014
  • Published:
Article QR Code